Effects of anatolian propolis and hypertonic saline combination nasal spray on allergic rhinitis symptoms: a prospective, multicenter study
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessAttributionNonCommercial 4.0https://creativecommons.org/licenses/by-nc/4.0/Tarih
2024Yazar
Cingi, CemalBayar Muluk, Nuray
Çukurova, İbrahim
Dündar, Rıza
Osma, Üstün
Bal, Cengiz
Zirek, Alaattin
Budak, Ali
Resuli, Ali Seyed
Selimoğlu, Asif
Tanuğur Samancı, Aslı Elif
Karaoğullarından, Ayşe
Yılmaz, Begüm
Arslan, Bengi
Sizer, Bilal
Cihan, Celalettin
Koca, Çiğdem Fırat
Avcı, Deniz
Aydenizöz, Doğukan
Ünver, Ethem
Alaskarov, Elvin
Gülmez, Emrah
Gündoğan, Fatih
Günay, Gözde
Çetiner, Hasan
Güngör, Hilal
Salcan, İsmail
Gündoğan, Mahmut Emre
Akbay, Makbule Özlem
Akdağ, Mehmet
Kaplama, Mehmet Erkan
Yaşar, Mehmet
Koparal, Mehtap
Kar, Murat
Altıntaş, Mustafa
Torun, Mümtaz Taner
Bozan, Nazım
Sarı, Neslihan
Susaman, Nihat
Küçük, Nurten
Erdoğan, Osman
Gül, Osman
Sancaklı, Özlem
Kundi, Pınar
Budak, Rezzan Okyay
Karaman, Sait
Taşar, Soner
Demir, Songül
Belli, Şeyda
Yağcı, Tarık
Bilici, Taylan
Çelik, Turgut
Yıldırım, Yavuz Sultan Selim
Atayoğlu, Ali Timuçin
Irkan, Reşat Kubilay
Zorlu, Duygu
Can, Demet
Üst veri
Tüm öğe kaydını gösterKünye
Cingi, C., Bayar Muluk, N., Çukurova, İ., Dündar, R., Osma, Ü., Bal, C. ... Can, D. (2024). Effects of anatolian propolis and hypertonic saline combination nasal spray on allergic rhinitis symptoms: a prospective, multicenter study. Ear, Nose and Throat Journal, 103(4), 190-198. http://dx.doi.org/10.1177/01455613231204209Özet
Objectives: This study aimed to evaluate how Rhinapi nasal spray affects symptoms of allergic rhinitis. Methods: In this prospective, multicenter, observational study, 10,000 patients (comprising 5028 males and 4972 females) exhibiting symptoms of allergic rhinitis (namely, nasal discharge, sneezing, nasal itching, and nasal obstruction) from different centers in different regions of Turkey were enrolled in the study between March 2022 and March 2023. All the patients wanted to participate in the study and were administered Rhinapi one puff to each nostril three times a day, for a period of 3 weeks. Total symptom scores, quality of life (QoL) scores, and otolaryngological examination scores were evaluated before and 3 weeks after treatment. Results: The scores for discharge from the nose, sneezing, nasal pruritus, and blockage of the nose all indicated improvement when compared to pre-medication and post-medication. This difference achieved statistical significance (P < .001). The mean total symptom score fell following treatment (P < .001): whilst the score was 11.09 +/- 3.41 before administering Rhinapi; after administration, the average score was 6.23 +/- 2.41. The mean QoL scores also altered after medication (P < .001), improving from a mean value of 6.44 +/- 1.55 to a mean of 7.31 +/- 1.24. Significant improvement was also noted in the scores for conchal color and degree of edema after the treatment had been administered (P < .001). Conclusion: The study demonstrates that Rhinapi nasal spray decreases total symptom scores, and results in improved QoL and otolaryngological examination scores. Propolis spray may be recommended for patients with allergic rhinitis alongside other treatments.
WoS Q Kategorisi
Q4Scopus Q Kategorisi
Q3Kaynak
Ear, Nose and Throat JournalCilt
103Sayı
4Koleksiyonlar
- Makale Koleksiyonu [3672]
- Makale Koleksiyonu [333]
- PubMed İndeksli Yayınlar Koleksiyonu [4080]
- Scopus İndeksli Yayınlar Koleksiyonu [6346]
- WoS İndeksli Yayınlar Koleksiyonu [6465]